US20230381430A1 - Method of Using Sealants in a Gas Arthroscopy Procedure - Google Patents
Method of Using Sealants in a Gas Arthroscopy Procedure Download PDFInfo
- Publication number
- US20230381430A1 US20230381430A1 US18/447,893 US202318447893A US2023381430A1 US 20230381430 A1 US20230381430 A1 US 20230381430A1 US 202318447893 A US202318447893 A US 202318447893A US 2023381430 A1 US2023381430 A1 US 2023381430A1
- Authority
- US
- United States
- Prior art keywords
- joint
- gas
- tourniquet
- arthroscopy
- sealant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 36
- 239000000565 sealant Substances 0.000 title abstract description 18
- 210000000281 joint capsule Anatomy 0.000 claims abstract description 17
- 238000001356 surgical procedure Methods 0.000 claims description 18
- 239000012530 fluid Substances 0.000 claims description 9
- 210000000629 knee joint Anatomy 0.000 claims description 6
- 210000000323 shoulder joint Anatomy 0.000 claims description 2
- 238000002513 implantation Methods 0.000 claims 1
- 239000007788 liquid Substances 0.000 abstract description 5
- 206010001526 Air embolism Diseases 0.000 abstract description 4
- 238000007789 sealing Methods 0.000 abstract description 3
- 239000003894 surgical glue Substances 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 7
- 210000000845 cartilage Anatomy 0.000 description 6
- 206010015866 Extravasation Diseases 0.000 description 4
- 230000036251 extravasation Effects 0.000 description 4
- 108010073385 Fibrin Proteins 0.000 description 3
- 102000009123 Fibrin Human genes 0.000 description 3
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 3
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 229950003499 fibrin Drugs 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- -1 Marcaine Chemical class 0.000 description 2
- 229920002873 Polyethylenimine Polymers 0.000 description 2
- 208000013201 Stress fracture Diseases 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 210000001503 joint Anatomy 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 239000003106 tissue adhesive Substances 0.000 description 2
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000024288 Rotator Cuff injury Diseases 0.000 description 1
- 206010042344 Subcutaneous emphysema Diseases 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000002639 bone cement Substances 0.000 description 1
- SIEYLFHKZGLBNX-UHFFFAOYSA-N bupivacaine hydrochloride (anhydrous) Chemical compound [Cl-].CCCC[NH+]1CCCCC1C(=O)NC1=C(C)C=CC=C1C SIEYLFHKZGLBNX-UHFFFAOYSA-N 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- NLCKLZIHJQEMCU-UHFFFAOYSA-N cyano prop-2-enoate Chemical class C=CC(=O)OC#N NLCKLZIHJQEMCU-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000005067 joint tissue Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000000608 laser ablation Methods 0.000 description 1
- 229940106885 marcaine Drugs 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000002355 open surgical procedure Methods 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000000513 rotator cuff Anatomy 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 210000001258 synovial membrane Anatomy 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000002303 tibia Anatomy 0.000 description 1
- 229940075469 tissue adhesives Drugs 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/34—Trocars; Puncturing needles
- A61B17/3474—Insufflating needles, e.g. Veress needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M13/00—Insufflators for therapeutic or disinfectant purposes, i.e. devices for blowing a gas, powder or vapour into the body
- A61M13/003—Blowing gases other than for carrying powders, e.g. for inflating, dilating or rinsing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/00491—Surgical glue applicators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/132—Tourniquets
- A61B17/135—Tourniquets inflatable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/34—Trocars; Puncturing needles
- A61B17/3478—Endoscopic needles, e.g. for infusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/02—Sprayers or atomisers specially adapted for therapeutic purposes operated by air or other gas pressure applied to the liquid or other product to be sprayed or atomised
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00004—(bio)absorbable, (bio)resorbable or resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00646—Type of implements
- A61B2017/0065—Type of implements the implement being an adhesive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/34—Trocars; Puncturing needles
- A61B17/3417—Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
- A61B2017/3419—Sealing means between cannula and body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00565—Bone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00577—Ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00601—Cutting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0413—Blood
- A61M2202/0445—Proteins
- A61M2202/0447—Glycoproteins
- A61M2202/045—Fibrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/02—Bones
Definitions
- the inventions described below relate to the field of gas arthroscopy.
- Arthroscopy of joints is a procedure performed nearly 8 million times per year and is done almost exclusively with fluid, particularly saline, to inflate a joint.
- fluid particularly saline
- Gas arthroscopy is not used because gas may travel along tissue planes and find its way into the venous system to cause embolisms or collect undesirably in locations distant from the surgical site. The problem with migration of gas from an arthroscopic joint space and the risks of air embolisms has previously been unsolved.
- Gas arthroscopy has significant potential clinical utility for procedures where a fluid medium is undesirable, such as where surgical adhesives such as fibrin glues and cyanoacrylates are used, and other procedures where a wet environment inhibits adhesion or washes away the adhesive.
- surgical adhesives such as fibrin glues and cyanoacrylates are used
- a wet environment inhibits adhesion or washes away the adhesive.
- the less desirable alternative to arthroscopy is an open procedure with the increased pain, scarring and recovery that goes with it.
- the methods described below make gas arthroscopy a safe alternative to an open procedure where a dry environment is required.
- the method involves the use of a surgical sealant to prevent gas leakage from the joint during the procedure.
- Flowable biocompatible surgical sealants such as polyethylene glycol (PEG), polyethyleneimine (PEI), fibrin, albumin, or gelatin are injected into an arthroscopic joint space before insufflation with gas.
- a tourniquet system for gas arthroscopy may also be used to inhibit extravasation of gas from an arthroscopic joint space.
- the tourniquet or cuff that surrounds the joint may also be used for a variety of joints to squeeze the tissue around the joint and restrict perfusion into the area for hemostasis.
- FIGS. 1 a , 1 b and 1 c show a method of performing gas arthroscopy using a surgical sealant.
- FIG. 2 shows a method of performing gas arthroscopy using a surgical sealant.
- FIGS. 3 a and 3 b show a method of performing gas arthroscopy using a surgical sealant.
- FIGS. 4 a and 4 b shows a tourniquet system for use during gas arthroscopy to prevent extravasation of gas into tissue.
- FIGS. 1 a , 1 b and 1 c show a method of performing gas arthroscopy using a surgical sealant.
- Various anatomical landmarks in the patient's knee joint 1 are shown for reference, including the femur 2 , the tibia 3 , the joint capsule 4 , the outer layer of the joint capsule 5 (i.e. the articular capsule), and the inner layer of the joint capsule 6 (i.e. the synovial membrane).
- FIG. 1 a shows the knee joint prior to surgery.
- a sealant 7 is injected into the joint capsule 4 through a delivery device 8 , as shown in FIG. 1 b .
- the knee joint may be manipulated to distribute the sealant.
- Gas 9 such as filtered air or carbon dioxide, is then introduced into the joint capsule 4 through a gas delivery device 10 , as shown in FIG. 1 c , causing the joint capsule to be inflated with gas prior to an arthroscopic surgical procedure.
- gas delivery device 10 as shown in FIG. 1 c .
- the result is an expanded, insufflated joint capsule lined by a layer of sealant and filled with insufflated fluid (preferably gas).
- gas is introduced into the knee joint, from an insufflator 11 through the gas delivery device, for example an arthroscope 12 , causing the joint capsule 4 to be inflated with gas.
- the surgical sealant prevents the leakage of gas from the joint space into the surrounding tissue planes and vasculature.
- the gas is released, either by opening the valve on the arthroscope and letting it deflate, or by removal of the surgical instruments.
- a flexible gas sealing portal 13 may be used in conjunction with the biologic delivery device 14 to ensure that the joint stays properly inflated.
- the sealant may be a gel, or a viscous liquid, or a lower viscosity fluid that may be cured if needed either by the mixing of the sealant with a static mixer before delivery, or with UV light.
- the sealant may also be loaded with anti-inflammatory medications such as steroids, anesthetics such as Marcaine, stem cells, or growth factors or other medications.
- the method may be used in a liquid saline environment, for example for minimization of extravasation during arthroscopic surgery.
- the sealant would have to be biocompatible and not dissolve too quickly in water, for example PVA (polyvinyl alcohol) can be made water resistant.
- FIGS. 3 a and 3 b show a method of performing gas arthroscopy using a surgical sealant wherein the surgical sealant is distributed in the joint with a sprayer prior to or after the insufflation of the joint with gas.
- the sealant may be injected into the site via a syringe 15 and an arthroscopic instrument 12 with the capability of spraying the sealant in the surgical site.
- the distal end of the arthroscopic sheath 16 has an aperture 17 capable of spraying the sealant.
- the sprayer may be part of a coaxial sheath that is over an arthroscope, part of the arthroscope, or the sprayer can also be a separate device with a spray nozzle.
- a flexible gas sealing portal 13 may be used while a surgeon performs surgery on the joint with, for example, the biologic delivery device 14 to ensure that the joint stays properly inflated.
- a tissue adhesive 18 e.g. fibrin glue
- a fluid delivery device 19 may be delivered through a fluid delivery device 19 to fix a biologic patch 20 in place during a biologic patch procedure.
- the surgeon injects the sealant into the knee joint and manipulates the joint to distribute the sealant.
- the sealant flows to fill holes, gaps and voids to form a barrier on the tissue defining the joint capsule.
- the joint space is inflated with gas.
- An arthroscope surgical procedure is performed. Upon completion of the procedure, the instruments are withdrawn and the gas escapes through the surgical portals.
- a gas-mediated procedure such as cartilage repair with a chopped cartilage conglomerate, biologic construct or cell-seeded membrane adhered in place with fibrin glue may be performed using a biologic delivery system.
- fibrin glue is used in a gas environment rather than a saline environment since tissue adhesives do not adhere properly under water.
- the types of sheet biologics that can be delivered are: bioinductive collagen sheets for partial rotator cuff tears, structural patches for superior capsular reconstruction (SCR) procedures, and collagen construct sheets seeded with stem cells made by companies such as the MACI cartilage patch (Vericel, Ann Arbor MI) for repairing cartilage defects.
- Other procedures not possible in a liquid environment may be performed such as laser ablation of diseased cartilage and preparation of the implant site, or laser-based microfracture.
- This dry arthroscopy system with a surgical sealant can facilitate a number of other procedures, such as delivery of bone cements for fracture repair, tacking down and repair of damaged cartilage and labral flaps, and repair of meniscal tears with adhesives instead of sutures.
- the system may also be used to repair partial rotator cuff tendon tears, and to adhere bioinductive repair constructs.
- the system and method may be used in other indications such as spinal procedures (where it is necessary to seal against cerebrospinal (CSF) fluid leaks), or neurosurgery where a sealed, dry surgical space needs to be created in a minimally-invasive way without an open surgical procedure.
- CSF cerebrospinal
- gas arthroscopy Another use for gas arthroscopy is when lasers are used that would otherwise be absorbed in a fluid medium (for example, use of a laser in a gas medium to perform microfracture is described in Kuctician, Method and Devices for Treating Damaged Articular Cartilage, U.S. Publ. No. 2009/0105792A1).
- FIGS. 4 a and 4 b illustrate a tourniquet system 21 for gas arthroscopy to prevent the spread of insufflation gas into the surrounding tissue (extravasation) and to keep it confined to the joint.
- This is a circumferential tourniquet wrap 22 , having a proximal tourniquet 22 p , a distal tourniquet 22 d , and an aperture.
- the tourniquet is configured to be placed around the joint 1 , to provide circumferential compression around the joint, and keep the gas in the joint and limit travel of any gas which enters the blood vessels around the joint. This prevents unwanted tissue dissection, air embolisms, and interstitial air pockets.
- FIG. 4 a shows a tourniquet system in a knee surgery, including the arthroscope 12 , biologic delivery device 14 , and bulb 23 .
- FIG. 4 b shows a tourniquet system in a shoulder surgery.
- the tourniquet wrap is placed around the shoulder joint 24 and inflated to cause circumferential compression around the joint. Gas is introduced into the joint capsule via an arthroscopic instrument. A surgical procedure is then performed. Upon completion of the surgical procedure, the gas is withdrawn, the tourniquet wrap deflated and removed.
- use of the tourniquet wrap in a method of performing arthroscopic surgery comprises the steps of constricting an area proximal to a joint with a tourniquet, constricting an area distal to the joint with a tourniquet, insufflating the joint with fluid, and performing an arthroscopic surgical procedure on the joint.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Optics & Photonics (AREA)
- Electromagnetism (AREA)
- Otolaryngology (AREA)
- Biophysics (AREA)
- Reproductive Health (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Surgical Instruments (AREA)
Abstract
Description
- This application is a continuation of U.S. application Ser. No. 16/412,263, filed May 14, 2019, which claims priority to U.S. Provisional Patent Application 62/671,303 filed May 14, 2018.
- The inventions described below relate to the field of gas arthroscopy.
- Arthroscopy of joints is a procedure performed nearly 8 million times per year and is done almost exclusively with fluid, particularly saline, to inflate a joint. (See R. T. Hegde, R. N. Avatgere; Air embolism during anesthesia for shoulder arthroscopy, BJA: British Journal of Anesthesia,
Volume Issue - Gas arthroscopy has significant potential clinical utility for procedures where a fluid medium is undesirable, such as where surgical adhesives such as fibrin glues and cyanoacrylates are used, and other procedures where a wet environment inhibits adhesion or washes away the adhesive. The less desirable alternative to arthroscopy is an open procedure with the increased pain, scarring and recovery that goes with it.
- The methods described below make gas arthroscopy a safe alternative to an open procedure where a dry environment is required. The method involves the use of a surgical sealant to prevent gas leakage from the joint during the procedure. Flowable biocompatible surgical sealants such as polyethylene glycol (PEG), polyethyleneimine (PEI), fibrin, albumin, or gelatin are injected into an arthroscopic joint space before insufflation with gas.
- A tourniquet system for gas arthroscopy may also be used to inhibit extravasation of gas from an arthroscopic joint space. The tourniquet or cuff that surrounds the joint may also be used for a variety of joints to squeeze the tissue around the joint and restrict perfusion into the area for hemostasis.
-
FIGS. 1 a, 1 b and 1 c show a method of performing gas arthroscopy using a surgical sealant. -
FIG. 2 shows a method of performing gas arthroscopy using a surgical sealant. -
FIGS. 3 a and 3 b show a method of performing gas arthroscopy using a surgical sealant. -
FIGS. 4 a and 4 b shows a tourniquet system for use during gas arthroscopy to prevent extravasation of gas into tissue. -
FIGS. 1 a, 1 b and 1 c show a method of performing gas arthroscopy using a surgical sealant. Various anatomical landmarks in the patient'sknee joint 1 are shown for reference, including thefemur 2, thetibia 3, thejoint capsule 4, the outer layer of the joint capsule 5 (i.e. the articular capsule), and the inner layer of the joint capsule 6 (i.e. the synovial membrane).FIG. 1 a shows the knee joint prior to surgery. Asealant 7 is injected into thejoint capsule 4 through a delivery device 8, as shown inFIG. 1 b . The knee joint may be manipulated to distribute the sealant. Gas 9, such as filtered air or carbon dioxide, is then introduced into thejoint capsule 4 through agas delivery device 10, as shown inFIG. 1 c , causing the joint capsule to be inflated with gas prior to an arthroscopic surgical procedure. The result is an expanded, insufflated joint capsule lined by a layer of sealant and filled with insufflated fluid (preferably gas). - As shown in
FIG. 2 , gas is introduced into the knee joint, from aninsufflator 11 through the gas delivery device, for example anarthroscope 12, causing thejoint capsule 4 to be inflated with gas. During the surgical procedure the surgical sealant prevents the leakage of gas from the joint space into the surrounding tissue planes and vasculature. Upon completion of the surgical procedure, the gas is released, either by opening the valve on the arthroscope and letting it deflate, or by removal of the surgical instruments. A flexiblegas sealing portal 13 may be used in conjunction with thebiologic delivery device 14 to ensure that the joint stays properly inflated. - Various types of surgical sealants may be used, such as polyurethane, polyethylene glycol, polyvinyl alcohol, glucose, fibrin, gelatin, albumin, polysaccharides, chitosan, dextran, and chondroitin sulfate. A short acting sealant that dissolves and is absorbed without causing irritation to the joint would be most preferable. Chondroitin sulfate and other chemistry systems in this group are known to be biocompatible with joint tissue. Preferably the sealant would be of balanced viscosity to penetrate into the joint opening where gas would leak out, but stick to surfaces of the joint space. The sealant may be a gel, or a viscous liquid, or a lower viscosity fluid that may be cured if needed either by the mixing of the sealant with a static mixer before delivery, or with UV light. The sealant may also be loaded with anti-inflammatory medications such as steroids, anesthetics such as Marcaine, stem cells, or growth factors or other medications.
- Though gas arthroscopy has been described, the method may be used in a liquid saline environment, for example for minimization of extravasation during arthroscopic surgery. The sealant would have to be biocompatible and not dissolve too quickly in water, for example PVA (polyvinyl alcohol) can be made water resistant.
-
FIGS. 3 a and 3 b show a method of performing gas arthroscopy using a surgical sealant wherein the surgical sealant is distributed in the joint with a sprayer prior to or after the insufflation of the joint with gas. The sealant may be injected into the site via asyringe 15 and anarthroscopic instrument 12 with the capability of spraying the sealant in the surgical site. As shown inFIG. 3 b , the distal end of thearthroscopic sheath 16 has anaperture 17 capable of spraying the sealant. The sprayer may be part of a coaxial sheath that is over an arthroscope, part of the arthroscope, or the sprayer can also be a separate device with a spray nozzle. A flexiblegas sealing portal 13 may be used while a surgeon performs surgery on the joint with, for example, thebiologic delivery device 14 to ensure that the joint stays properly inflated. A tissue adhesive 18 (e.g. fibrin glue) may be delivered through afluid delivery device 19 to fix abiologic patch 20 in place during a biologic patch procedure. - In use, the surgeon injects the sealant into the knee joint and manipulates the joint to distribute the sealant. The sealant flows to fill holes, gaps and voids to form a barrier on the tissue defining the joint capsule. The joint space is inflated with gas. An arthroscope surgical procedure is performed. Upon completion of the procedure, the instruments are withdrawn and the gas escapes through the surgical portals.
- Various medical procedures that are not possible in a liquid environment may be performed using this method. A gas-mediated procedure such as cartilage repair with a chopped cartilage conglomerate, biologic construct or cell-seeded membrane adhered in place with fibrin glue may be performed using a biologic delivery system. Ideally the use of fibrin glue is used in a gas environment rather than a saline environment since tissue adhesives do not adhere properly under water. The types of sheet biologics that can be delivered are: bioinductive collagen sheets for partial rotator cuff tears, structural patches for superior capsular reconstruction (SCR) procedures, and collagen construct sheets seeded with stem cells made by companies such as the MACI cartilage patch (Vericel, Ann Arbor MI) for repairing cartilage defects. Other procedures not possible in a liquid environment may be performed such as laser ablation of diseased cartilage and preparation of the implant site, or laser-based microfracture.
- This dry arthroscopy system with a surgical sealant can facilitate a number of other procedures, such as delivery of bone cements for fracture repair, tacking down and repair of damaged cartilage and labral flaps, and repair of meniscal tears with adhesives instead of sutures. The system may also be used to repair partial rotator cuff tendon tears, and to adhere bioinductive repair constructs. The system and method may be used in other indications such as spinal procedures (where it is necessary to seal against cerebrospinal (CSF) fluid leaks), or neurosurgery where a sealed, dry surgical space needs to be created in a minimally-invasive way without an open surgical procedure. Another use for gas arthroscopy is when lasers are used that would otherwise be absorbed in a fluid medium (for example, use of a laser in a gas medium to perform microfracture is described in Kucklick, Method and Devices for Treating Damaged Articular Cartilage, U.S. Publ. No. 2009/0105792A1).
-
FIGS. 4 a and 4 b illustrate atourniquet system 21 for gas arthroscopy to prevent the spread of insufflation gas into the surrounding tissue (extravasation) and to keep it confined to the joint. This is a circumferential tourniquet wrap 22, having aproximal tourniquet 22 p, adistal tourniquet 22 d, and an aperture. The tourniquet is configured to be placed around thejoint 1, to provide circumferential compression around the joint, and keep the gas in the joint and limit travel of any gas which enters the blood vessels around the joint. This prevents unwanted tissue dissection, air embolisms, and interstitial air pockets. The tourniquet wrap compresses closely to the joint to prevent unwanted subcutaneous emphysema in the soft tissue between the tourniquet wrap and the joint.FIG. 4 a shows a tourniquet system in a knee surgery, including thearthroscope 12,biologic delivery device 14, andbulb 23.FIG. 4 b shows a tourniquet system in a shoulder surgery. The tourniquet wrap is placed around theshoulder joint 24 and inflated to cause circumferential compression around the joint. Gas is introduced into the joint capsule via an arthroscopic instrument. A surgical procedure is then performed. Upon completion of the surgical procedure, the gas is withdrawn, the tourniquet wrap deflated and removed. Generally, use of the tourniquet wrap in a method of performing arthroscopic surgery comprises the steps of constricting an area proximal to a joint with a tourniquet, constricting an area distal to the joint with a tourniquet, insufflating the joint with fluid, and performing an arthroscopic surgical procedure on the joint. - While the preferred embodiments of the devices and methods have been described in reference to the environment in which they were developed, they are merely illustrative of the principles of the inventions. The elements of the various embodiments may be incorporated into each of the other species to obtain the benefits of those elements in combination with such other species, and the various beneficial features may be employed in embodiments alone or in combination with each other. Other embodiments and configurations may be devised without departing from the spirit of the inventions and the scope of the appended claims.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18/447,893 US20230381430A1 (en) | 2018-05-14 | 2023-08-10 | Method of Using Sealants in a Gas Arthroscopy Procedure |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862671303P | 2018-05-14 | 2018-05-14 | |
US16/412,263 US11759582B2 (en) | 2018-05-14 | 2019-05-14 | Method of using sealants in a gas arthroscopy procedure |
US18/447,893 US20230381430A1 (en) | 2018-05-14 | 2023-08-10 | Method of Using Sealants in a Gas Arthroscopy Procedure |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/412,263 Continuation US11759582B2 (en) | 2018-05-14 | 2019-05-14 | Method of using sealants in a gas arthroscopy procedure |
Publications (1)
Publication Number | Publication Date |
---|---|
US20230381430A1 true US20230381430A1 (en) | 2023-11-30 |
Family
ID=68464966
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/412,263 Active 2041-07-30 US11759582B2 (en) | 2018-05-14 | 2019-05-14 | Method of using sealants in a gas arthroscopy procedure |
US18/447,893 Pending US20230381430A1 (en) | 2018-05-14 | 2023-08-10 | Method of Using Sealants in a Gas Arthroscopy Procedure |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/412,263 Active 2041-07-30 US11759582B2 (en) | 2018-05-14 | 2019-05-14 | Method of using sealants in a gas arthroscopy procedure |
Country Status (1)
Country | Link |
---|---|
US (2) | US11759582B2 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030032994A1 (en) * | 2001-07-30 | 2003-02-13 | Dew Douglas K. | Apparatus and method for joint surgery |
US20060258560A1 (en) * | 2002-09-30 | 2006-11-16 | Chunlin Yang | Dry tissue sealant compositions |
US20160066770A1 (en) * | 2014-04-02 | 2016-03-10 | Visionscope Technologies Llc | Devices and methods for minimally invasive arthroscopic surgery |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7572251B1 (en) * | 1995-06-07 | 2009-08-11 | Arthrocare Corporation | Systems and methods for electrosurgical tissue treatment |
US5720894A (en) * | 1996-01-11 | 1998-02-24 | The Regents Of The University Of California | Ultrashort pulse high repetition rate laser system for biological tissue processing |
US20040018228A1 (en) * | 2000-11-06 | 2004-01-29 | Afmedica, Inc. | Compositions and methods for reducing scar tissue formation |
US20070077236A1 (en) * | 2003-06-12 | 2007-04-05 | Interface Biotech A/S | Method for cell implantation |
US20080069855A1 (en) * | 2006-08-21 | 2008-03-20 | Bonutti Peter M | Method of inhibiting the formation of adhesions and scar tissue and reducing blood loss |
US10953128B2 (en) * | 2017-11-02 | 2021-03-23 | St. Teresa Medical, Inc. | Fibrin sealant products |
-
2019
- 2019-05-14 US US16/412,263 patent/US11759582B2/en active Active
-
2023
- 2023-08-10 US US18/447,893 patent/US20230381430A1/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030032994A1 (en) * | 2001-07-30 | 2003-02-13 | Dew Douglas K. | Apparatus and method for joint surgery |
US20060258560A1 (en) * | 2002-09-30 | 2006-11-16 | Chunlin Yang | Dry tissue sealant compositions |
US20160066770A1 (en) * | 2014-04-02 | 2016-03-10 | Visionscope Technologies Llc | Devices and methods for minimally invasive arthroscopic surgery |
Non-Patent Citations (3)
Title |
---|
Annabi N, Yue K, Tamayol A, Khademhosseini A. Elastic sealants for surgical applications. Eur J Pharm Biopharm. 2015 Sep;95(Pt A):27-39. doi: 10.1016/j.ejpb.2015.05.022. Epub 2015 Jun 12. PMID: 26079524; PMCID: PMC4591192. (Year: 2015) * |
Imbert, P., Schlatterer, B. A risk–benefit analysis of alternating low-pressure CO2 insufflation and fluid medium in arthroscopic knee ACL reconstruction. Knee Surg Sports Traumatol Arthrosc 22, 1483–1490 (2014). https://doi.org/10.1007/s00167-013-2474-3 (Year: 2014) * |
Romanò, C.L., Monti, L., Logoluso, N. et al. Does a thrombin-based topical haemostatic agent reduce blood loss and transfusion requirements after total knee revision surgery? A randomized, controlled trial. Knee Surg Sports Traumatol Arthrosc 23, 3337–3342 (2015). (Year: 2015) * |
Also Published As
Publication number | Publication date |
---|---|
US11759582B2 (en) | 2023-09-19 |
US20190344022A1 (en) | 2019-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10004605B2 (en) | Resilient knee implant and methods | |
US9198673B2 (en) | Localized cartilage defect therapy | |
US8337557B2 (en) | Apparatus and kit for injecting a curable biomaterial into an intervertebral space | |
US12377193B2 (en) | Indirect method of articular tissue repair | |
US20160030025A1 (en) | Vascular wound closure device and method | |
CN104144651B (en) | System and method for treating the fistula in lung and tracheae | |
US20080221527A1 (en) | Arthroscopic harvesting and therapeutic application of bone marrow aspirate | |
US20090299373A1 (en) | Kyphoplasty banded balloon catheter | |
JP2009532080A (en) | System and method for transcutaneously delivering reduced pressure therapy using a fluid manifold | |
US8181643B2 (en) | System and method for detection and repair of pulmonary air leaks | |
JP2008508980A (en) | Nucleus nucleus prosthesis device and method | |
TW201029692A (en) | Manifolds, systems, and methods for administering reduced pressure to a subcutaneous tissue site | |
US20060015004A1 (en) | Hemostatic device and methods | |
US20230381430A1 (en) | Method of Using Sealants in a Gas Arthroscopy Procedure | |
US9622804B2 (en) | Void containment apparatus and method of use for creating a sealed environment for product delivery | |
US20240382315A1 (en) | Inflatable Prosthesis, Delivery Tools Therefor, Implantation Method Therefor, And Manufacturing Method Therefor | |
WO2022256436A1 (en) | Systems, methods, and apparatus for closing an opening in the dura mater | |
NZ748139B2 (en) | Devices for articular tissue repair | |
BRPI0709322A2 (en) | reduced pressure delivery system for applying reduced pressure tissue treatment to a tissue site and method of administering a reduced pressure tissue treatment to a tissue site |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: CANNUFLOW, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KUCKLICK, THEODORE R.;REEL/FRAME:064566/0926 Effective date: 20190613 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |